Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy

  1. Lookup NU author(s)
  2. Dr David Jamieson
  3. Dr Nicola Cresti
  4. Julieann Sludden
  5. Melanie Griffin
  6. Nahed Hawsawi
  7. Emily Mould
  8. Dr Mark Verrill
  9. Dr Felicity May
  10. Professor Alan Boddy
Author(s)Jamieson D, Cresti N, Bray J, Sludden J, Griffin MJ, Hawsawi NM, Famie E, Mould EVA, Verrill MW, May FEB, Boddy AV
Publication type Article
JournalPharmacogenetics and Genomics
Year2011
Volume21
Issue12
Pages808-819
ISSN (print)1744-6872
ISSN (electronic)1744-6880
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherLippincott Williams & Wilkins
URLhttp://dx.doi.org/10.1097/FPC.0b013e32834b6918
DOI10.1097/FPC.0b013e32834b6918
Actions    Link to this publication